# A Study of LC542019 in Healthy Subjects and Subjects With T2DM

> **NCT06333977** · PHASE1 · COMPLETED · sponsor: **LG Chem** · enrollment: 100 (actual)

## Conditions studied

- Healthy
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** LC542019
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06333977
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-25
- **Primary completion:** 2023-12-14
- **Final completion:** 2023-12-14
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06333977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06333977, "A Study of LC542019 in Healthy Subjects and Subjects With T2DM". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06333977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*